Jean-Charles Aurégan1, Raphaël Pietton2, Thierry Bégué2, Philippe Anract3, David Biau3. 1. Department of Orthopedic Surgery and Traumatology, Antoine Béclère Hospital, AP-HP, Paris Sud University, 157 rue de la Porte de Trivaux, 92140, Clamart, France. aureganjc@yahoo.fr. 2. Department of Orthopedic Surgery and Traumatology, Antoine Béclère Hospital, AP-HP, Paris Sud University, 157 rue de la Porte de Trivaux, 92140, Clamart, France. 3. Department of Orthopedic Surgery and Traumatology, Cochin Teaching Hospital, AP-HP, Paris Descartes University, INSERM U1153, 27 rue du Faubourg Saint-Jacques, 75014, Paris, France.
Abstract
INTRODUCTION: Allograft-prosthesis composite reconstruction after resection of a primary bone tumor may have theoretical advantages, such as restoration of bone stock and soft tissue attachments. However, the reported results of APC of different anatomical sites differ widely. We conducted a meta-analysis to estimate the revision and infection rates associated with allograft-prosthesis composite (APC) reconstructions after resection of a primary bone tumor. We looked for variables, such as anatomic sites and irradiation of the allograft, associated with these outcomes. MATERIALS AND METHODS: We searched Medline, EMBASE, and Cochrane Library. The primary outcome was the revision rate, and the secondary outcome was the infection rate. Random effects meta-analyses of single proportions were used to estimate pooled rates of events. Meta-regression models were built to assess the effect of moderators on relevant both outcomes. RESULTS: Thirty-one studies were included: 9 about acetabulum APC, 9 about proximal femur APC, 4 about proximal tibia APC, and 9 about proximal humerus APC. The revision rates ranged from 16 % (95 % CI 10-25 %) for proximal humerus to 38 % (95 % CI 26-52 %) for acetabulum, and were significantly different between anatomic sites (p = 0.028). The infection rates ranged from 8 % (95 % CI 4-16 %) for proximal humerus to 23 % (95 % CI 16-33 %) for proximal tibia and 23 % (95 % CI 15-35 %) acetabulum APCs, and were significantly different between anatomic sites (p = 0.008). Finally, we found that irradiation of the allograft was significantly associated with revision rates (p = 0.033) and infection rates (p < 0.001). CONCLUSIONS: Results of an APC reconstruction after resection of a primary malignant bone tumor vary significantly between anatomic sites and after irradiation of the allograft.
INTRODUCTION: Allograft-prosthesis composite reconstruction after resection of a primary bone tumor may have theoretical advantages, such as restoration of bone stock and soft tissue attachments. However, the reported results of APC of different anatomical sites differ widely. We conducted a meta-analysis to estimate the revision and infection rates associated with allograft-prosthesis composite (APC) reconstructions after resection of a primary bone tumor. We looked for variables, such as anatomic sites and irradiation of the allograft, associated with these outcomes. MATERIALS AND METHODS: We searched Medline, EMBASE, and Cochrane Library. The primary outcome was the revision rate, and the secondary outcome was the infection rate. Random effects meta-analyses of single proportions were used to estimate pooled rates of events. Meta-regression models were built to assess the effect of moderators on relevant both outcomes. RESULTS: Thirty-one studies were included: 9 about acetabulum APC, 9 about proximal femur APC, 4 about proximal tibia APC, and 9 about proximal humerus APC. The revision rates ranged from 16 % (95 % CI 10-25 %) for proximal humerus to 38 % (95 % CI 26-52 %) for acetabulum, and were significantly different between anatomic sites (p = 0.028). The infection rates ranged from 8 % (95 % CI 4-16 %) for proximal humerus to 23 % (95 % CI 16-33 %) for proximal tibia and 23 % (95 % CI 15-35 %) acetabulum APCs, and were significantly different between anatomic sites (p = 0.008). Finally, we found that irradiation of the allograft was significantly associated with revision rates (p = 0.033) and infection rates (p < 0.001). CONCLUSIONS: Results of an APC reconstruction after resection of a primary malignant bone tumor vary significantly between anatomic sites and after irradiation of the allograft.
Entities:
Keywords:
Allograft prosthesis composite; Infection, irradiation; Malignant bone tumor; Revision